Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
 
Prescribed Drug Estimates: 2002

Table 1.1 Top Prescribed Drugs by Total Expenditures, 2002

Prescribed
drug name

Total expenditures
ranking

Total
expenditures
Total number of
persons with expenditures

Lipitor
1
5,910,175,798

11,301,794

Zocor
2
4,405,554,171

6,941,974

Prevacid
3
2,964,258,322

5,294,860

Prilosec
4
2,600,167,199

3,729,057

Celebrex
5
2,375,845,406

6,715,554

Paxil
6
2,242,121,858

4,969,058

Pravachol
7
2,131,296,694

2,804,833

Zoloft
8
2,101,947,914

5,030,240

Claritin
9
2,069,379,771

8,989,933

Norvasc
10
2,063,809,540

5,539,168


Standard Errors for Table 1.1: Top Prescribed Drugs by Total Expenditures, 2002

Prescribed
drug name
Total
expenditures
Total number of
persons with expenditures

Lipitor
312,050,328.14
473,718.40
Zocor
400,257,828.83
350,714.64
Prevacid
182,567,019.88
263,766.55
Prilosec
192,522,494.32
230,631.43
Celebrex
154,936,933.81
314,442.26
Paxil
136,861,558.19
236,287.48
Pravachol
187,196,053.54
199,211.11
Zoloft
153,938,863.18
279,739.23
Claritin
99,354,905.73
335,882.32
Norvasc
131,463,356.83
298,045.51

 

 


MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov